Technical Analysis for AEON - AEON Biopharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.62 | 0.87% | 0.01 |
AEON closed up 0.87 percent on Friday, November 15, 2024, on 88 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 0.87% | |
| Lower Bollinger Band Walk | Weakness | 0.87% | |
| New 52 Week Low | Weakness | 0.87% | |
| Stochastic Reached Oversold | Weakness | 0.87% |
| Alert | Time |
|---|---|
| Rose Above Lower Bollinger Band | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| Up 5% | 1 day ago |
| Up 3% | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Botulinum Toxin Dystonia
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Botulinum Toxin Dystonia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.17 |
| 52 Week Low | 0.6009 |
| Average Volume | 148,309 |
| 200-Day Moving Average | 3.83 |
| 50-Day Moving Average | 0.91 |
| 20-Day Moving Average | 0.87 |
| 10-Day Moving Average | 0.77 |
| Average True Range | 0.09 |
| RSI (14) | 29.08 |
| ADX | 22.0 |
| +DI | 15.82 |
| -DI | 33.78 |
| Chandelier Exit (Long, 3 ATRs) | 0.90 |
| Chandelier Exit (Short, 3 ATRs) | 0.86 |
| Upper Bollinger Bands | 1.12 |
| Lower Bollinger Band | 0.61 |
| Percent B (%b) | 0.01 |
| BandWidth | 58.58 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0308 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.70 | ||||
| Resistance 3 (R3) | 0.71 | 0.68 | 0.69 | ||
| Resistance 2 (R2) | 0.68 | 0.66 | 0.68 | 0.68 | |
| Resistance 1 (R1) | 0.65 | 0.65 | 0.67 | 0.65 | 0.68 |
| Pivot Point | 0.63 | 0.63 | 0.63 | 0.62 | 0.63 |
| Support 1 (S1) | 0.59 | 0.60 | 0.61 | 0.59 | 0.56 |
| Support 2 (S2) | 0.57 | 0.59 | 0.57 | 0.55 | |
| Support 3 (S3) | 0.54 | 0.57 | 0.55 | ||
| Support 4 (S4) | 0.53 |
